Complete regression of advanced esophageal cancer with abdominal bulky lymph node metastasis treated by concurrent chemoradiotherapy using docetaxel, cisplatin, and 5-fluorouracil

Esophagus

Volumn 6, Issue 3, 2009, Pages 183-187

  Kubota, Keisuke ^a   Mafune, Ken Ichi ^a   Yamada, Kazuhiko ^b   Yamashita, Hideomi ^b   Kuroda, Junko ^a   Aikou, Susumu ^b   Kaminishi, Michio ^c  

^a International University of Health and Welfare Mita Hospital   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Showa General Hospital   (Japan)

Author keywords

Chemoradiotherapy; Docetaxel; Esophageal carcinoma

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; DRUG FEVER; ESOPHAGUS CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PRIORITY JOURNAL; RADIATION DOSE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 70349300652     PISSN: 16129059     EISSN: 16129067     Source Type: Journal    
DOI: 10.1007/s10388-009-0186-z     Document Type: Article

References (28)

1. J.D. Urschel H. Vasan 2003 A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg 185 538 543
2. F. Fiorica D. Di Bona F. Schepis A. Licata L. Shahied A. Venturi, et al. 2004 Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and metaanalysis Gut 53 925 930
3. T.N. Walsh N. Noonan D. Hollywood A. Kelly N. Keeling T.P. Hennessy 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 462 467
4. S.G. Urba M.B. Orringer A. Turrisi M. Iannettoni A. Forastiere M. Strawderman 2001 Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 305 313
5. A. Ohtsu N. Boku K. Muro K. Chin M. Muto S. Yoshida, et al. 1999 Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus J Clin Oncol 17 2915 2912
6. K. Ishida N. Ando S. Yamamoto H. Ide M. Shinoda 2004 Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516) Jpn J Clin Oncol 34 615 619
7. Y. Nishimura M. Suzuki K. Nakamatsu S. Kanamori Y. Yagyu H. Shigeoka 2002 Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula Int J Radiat Oncol Biol Phys 53 134 139
8. M. Al Sarraf K. Martz A. Herskovic L. Leichman J.S. Brindle V.K. Vaitkevicius, et al. 1997 Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study J Clin Oncol 15 277 284
9. B.D. Minsky T.F. Pajak R.J. Ginsberg T.M. Pisansky J. Martenson R. Komaki, et al. 2002 INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy J Clin Oncol 20 1167 1174
10. J.S. Cooper D.M. Guo A. Herskovic J.S. Macdonald J.A. Martenson Jr M. Al-Sarraf, et al. 1999 Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01) JAMA 281 1623 1627
11. A.I. Einzig D. Neuberg S.C. Remick D.D. Karp P.J. O'Dwyer J.A. Stewart, et al. 1996 Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293 Med Oncol 13 87 93
12. S. Coenraad F. Carla N.M. Nombulelo W. Burger 1999 A phase II study of docetaxel in advanced, inoperable squamous carcinoma of the esophagus Proc Am Soc Clin Oncol 18 A1151
13. A. Mauer D. Haraf M. Ferguson M. Posner A. Sandler K. Kesler, et al. 2000 Docetaxel-based combined modality therapy for locally advanced carcinoma of the esophagus and gastric cardia Proc Am Soc Clin Oncol 19 A954
14. F. Pasini G. de Manzoni C. Pedrazzani A. Grandinetti E. Durante M. Gabbani, et al. 2005 High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy Ann Oncol 16 1133 1139
15. F. Pasini G. de Manzoni A. Grandinetti C. Pedrazzani C. Griso T. Sava, et al. 2006 Neoadjuvant combined modality therapy with weekly docetaxel (D) and cisplatin (P), 5-fluorouracil (5FU) continuous infusion (c.i.) and concurrent radiotherapy (RT) provides high pathological response rate in esophageal cancers (EC): a phase II study Proc Am Soc Clin Oncol 24 A4057
16. A. D. Roth C. de Pree S. Balmer-Manjo O. Huber A. Spiliopoulos M. Brundler, et al. 2001 Curative preoperative docetaxel-cisplatin-5-FU combined with hyperfractionated radiation in locally advanced esophageal cancer. A phase I/II study (abstract 639) Proc Am Soc Clin Oncol 20 A161
17. K. Mafune K. Yamada K. Imamura K. Kubota M. Kaminishi 2006 Docetaxel, 5-fluorouracil and nedaplatin as second-line chemotherapy for patients with esophageal cancer after esophagectomy: a pilot study J Clin Oncol 24 14140
18. Sobin L H, Wittekind C (eds) TNM Classification of malignant tumours: International Union Against Cancer, 5th edn. New York: Wiley; 1997.
19. DCTD, NCI, NIH, DHHS. Common terminology criteria for adverse events v3.0 (CTCAE). Published date: December 12, 2003 ( http://ctep.cancer.gov ).
20. H. Katori M. Tsukuda 2005 Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs. concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck Clin Oncol (R Coll Radiol) 17 148 152 (Pubitemid 40468479)
21. M.G. Ghi A. Paccagnella P. D'Amanzo C.A. Mione S. Fasa S. Paro, et al. 2004 Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study Int J Radiat Oncol Biol Phys 59 481 487
22. J. Janinis M. Papadakou G. Panagos A. Panousaki V. Georgoulias D. Hatzidaki, et al. 2001 Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer Am J Clin Oncol 24 227 231
23. M. Yano T. Tsujinaka H. Shiozaki M. Inoue Y. Doki M. Yamamoto, et al. 1999 Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus J Surg Oncol 70 25 32
24. T. Noguchi H. Moriyama S. Wada S. Takeno M. Wakisaka H. Mori, et al. 2003 Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma Dis Esophagus 16 94 98
25. K. Ikeda K. Ishida N. Sato K. Koeda K. Aoki Y. Kimura, et al. 2001 Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs Dis Esophagus 14 197 201
26. H. Fujita S. Sueyoshi T. Tanaka Y. Tanaka S. Matono N. Mori, et al. 2005 Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery World J Surg 29 25 31
27. O. Hagry W. Coosemans P. De Leyn P. Nafteux D. Van Raemdonck E. Van Cutsem, et al. 2003 Effects of preoperative chemoradiotherapy on postsurgical morbidity and mortality in cT3-4 +/- cM1 lymph cancer of the oesophagus and gastro-esophageal junction Eur J Cardiothorac Surg 24 179 186
28. M. Stahl M. Stuschke N. Lehmann H.J. Meyer M.K. Walz S. Seeber, et al. 2005 Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2310 2317